FDA Inspection
Paul W. Wallace, MDPaul W. Wallace, MD – FDA Inspection, Jun 8, 2018
Record Details
This FDA Inspection record concerns Paul W. Wallace, MD, with an inspection on June 8, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 3527f127-26e3-41e1-9e59-f8fa618a9260
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1055969
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.62(c)Record retention
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Paul W. Wallace, MD
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 17, 2026 | Not classified | Los Angeles District Office | Bioresearch Monitoring: Human Drugs |
| June 16, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Paul W. Wallace, MD
- FDA Inspection 1307736 - 2026-03-17
- FDA Inspection 1208694 - 2023-06-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.